Skip to main content

Streptozotocin

ALX-380-010

41 citations

  • ALX-380-010-5100   —   5x100 mg
    $164.00
  • ALX-380-010-G001   —   1 g
    $180.00
  • Highly pure O-GlcNAcase inhibitor
  • Compound commonly used to induce diabetes in vivo
  • Highly cited

Streptozotocin (STZ) is a glucosamine-nitrosourea widely used as an inhibitor of O-GlcNAcase in b-cells to induce diabetes in rodents. Once entered inside b-cells via the glucose transporter GLUT2, STZ causes alkylation of DNA, activation of poly ADP-ribosylation, depletion of cellular ATP and NAD+, generation of superoxide radicals, and ultimately elimination of b-cells. STZ acts also as a nitric oxide (NO) donor and vasorelaxant capable of relaxing phenylephrine-contracted aortic rings at 10µM. STZ is a potent methylating agent for DNA.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only


Last modified: May 29, 2024